Ca2+ fluxes in particular play a vital role in metabolic regulation in all cells and species (1, 2). Whereas rapid Ca2+ mobilization can be induced by an array of stimuli (reviewed in refs 3, 4) , it is becoming clear that signaling cross-talk whereby receptors couple multiple pathways is crucial in a variety of Ca2+de pendent physiological events (5-9). In addition, a number of hormonal stimuli acting alone appear capable of generating more than one second messenger.
In this article we examine examples of receptors that couple multiple signaling pathways and present views about how added sensitivity and the potential for cross-talk is built into these.
THE SIGNALING PATHWAY
GTP-binding proteins (C-proteins)2 located in the plasma membrane interact with the cytoplasmic loops of receptor proteins, thereby transfen'ing information to effector molecules such as adenylate cyclase and phospholipase C (PLC) (see, for example, ref 10 for one of many reviews). These molecules generate various second messengers, which in turn induce a range of cellular physiological responses often concomitant with mobilization of intracellular and extracellular Ca2t The role of the -and y-subunits of G-proteins in signaling is not as clear as that of the a-subunit, which plays the major role in signaling. The fact that, for example, the p-subunit is highly conserved between protein types (11) implies an important role. There are suggestions that certain G-proteins may be able to provide more than one type of regulation through specific signaling by the f-'y components in addition to the a-subunit. that besides an ability to generate its"traditional" second messenger cyclicAMP, glucagon also mobilizes Ca2, possibly through generating the Ca2 +..mobilizing second messenger 1P3. The extent to which each second messenger is generated, however, appears to be largely a function of the concentration of glucagon used (see Fig. 1 ). Fig. 1 ). This observation in particular has led to speculation regarding the mechanism by which these receptors are able to activate multiple effector systems. Chabre et al. (38), on the one hand, suggest it is unlikely that these two pathways are mediated by a single G-protein.
C, directly activates adenylate cyclase, and they found that it is most likely a member of the G,1 class that mediates the stimulation of PLC. The observations regarding agonist concentrations are consistent with the suggestion that the binding of the calcitonin receptor to a C-protein, which mediates the adenylate cyclase pathway, may be more efficient than to the G-protein coupled to PLC (38). However, Chakraborty et al. (41) have suggested that the efficiency of coupling may change during different stages of the cell cycle. These effects may mean that the PLC system becomes the predominant one during certain phases of cell growth. Alternatively, Birnbaumer (42) suggests that the stimulation of PLC could be due to the generation of G5-derived 3-?diIners, which provide an additional signal only at higher concentrations of agonist. Sequence analysis of the calcitonin receptor has shown that its third intracellular loop is similar to that of the parathyroid hormone receptor (43, 44) .
Receptors other than the subclass to which glucagon, PTH, and calcitonin belong also are able to couple to multiple signaling pathways. For example, Horn eta1. (45) Physiologically, the fact that the PACAP receptor can couple to more than one signaling system is quite significant because PACAP is an important regulator of pituitary cell function. If both pathways exist in the same cells, this also raises the possibility of a more complex signal dependent on cross-talk between the two pathways.
CROSS-TALK THROUGH SHARING OF G-PROTEINS
Dasso and Taylor (53) have examined the interaction between certain Ca2 Lmobilizing agonists and their G-proteins in hepatocytes.
They found that the Vi-vasopressin receptorand cti-adrenoreceptors appeared to share a pool of C-proteins.
Although the activated vasopressin receptors could prevent cLi-adrenoreceptors from associating with Cproteins, however, the reverse did not occur.
The authors suggested two explanations for this. Either 1) both receptors share a common C-protein pool, but the V1 receptor (when occupied by vasopressin) may have a greater affinity for the C-protein than the adrenoreceptor when occupied by its agonist or 2) the two receptors share a C-protein pool, but the Vi-receptors also have access to another source of C-proteins not available to Ui-adrenoreceptors. With either explanation, evidence clearly shows that two different receptors are able to share a common C-protein.
This idea raises more questions on the issue of how the different receptors are then able to evoke different, specific Ca2-mobilizing signals. A similar issue was investigated in terms of the apparent sharing of C2 between thrombin and cX2-adrenergic receptors in human platelet cells (54). Thrombin triggers the activation of PLC as well as the inhibition of adenylate cyclase; this is mediated by C2, which is the predominant C-protein species in these cells. by cyclic AMP generated by C,-activated adenylate cyclase (Fig. 2a) . This involves communication between two pathways stimulated by the same receptor by means of one of the possible mechanisms described previously. At the same time adenosine, acting through its own receptor and C1, is able to attenuate adenylate cyclase activity and consequently the generation of cyclic AMP. This in turn would reduce the likelihood of cyclic AMP-induced phosphorylation of PLC and result in an increase in the generation of IP3 via PLC (Fig. 2b) . This regulation thus involves cross-talk between pathways stimulated by two different receptors. Specifically it would appear that a cyclic AMP-dependent protein kinase is able to phosphorylate the IP3 receptor responsible for Ca2+ efflux from the endoplasmic reticulum. According to Burgess et al. (29) this action shifts the doseresponse curve for IP3-mediated Ca2+ release to the left by a factor of 4 and increases the total amount ofCa2+ released by 25%. It is of some interest that this shift in the dose-response curve mimics in qualitative terms data of Altin and Bygrave (55), where the copresence of glucagon with a Ca2-mobi1izing agonist was found to greatly increase the sensitivity of Ca2 influx in the perfused rat liver to the (Ca2-mobilizing) agonist, and data from Morgan et al. (56) that showed agonist-receptor binding was increased in the presence of glucagon.
In a related study using hepatocytes, Joseph and Ryan (57) concluded that the major effect of cyclic AMP-induced phosphorylation of the 1P3 receptor is an enhanced Ca2+ sensitivity of ligand binding to a high-affinity binding site. They suggest that the native receptor is subject to an inhibitory constraint that is relieved by Ca2, and that the phosphorylation state of the 1P3 receptor is an additional regulatory factor that determines the response of intracellular Ca2 stores to changes in both 1P3 and Ca2 (57). The importance of the phosphorylation state of the IP3 receptor in signaling cross-talk between 1P3 and cyclic AMP was also considered by Mauger et al. (58) . The extent to which phenomena similar to these might contribute to the modulation of other cellular Ca2+ transporters, particularly those involved in plasma membrane Ca2+ fluxes, remains to be assessed. Figure   3 outlinespossiblemodels that might account for cross-talk between cellular signal transducing systems discussed earlier. The glucagon, parathyroid hormone, calcitonin,and thyrotropin receptorsare allable to stimulatetwo alternative signaling pathways within the cell (Fig. 3b) . It is likely that these receptors use a specific C-protein to activate a specific receptor, although the question as to how this regulation is achieved at a molecular level remains. Other systems, such as the vasopressin and a-adrenergic receptors in hepatocytes and the thrombin and cZ-adrenergic receptors in platelet cells, have been shown to use the same C-protein to produce different signals (Fig. 3c) . This may be achieved through responses to agonist concentration changes that affect binding specificities or through the possible role played by 3-y subunits in direct signal regulation. Also, cross-talk can occur between two signaling pathways activated by different receptors through sharing of the same C-proteins as well as after the (inter)action of the second messengers generated (Fig. 3d) . These separate models are thus compatible in the sense that all of these possibilities are able to coexist. It is communication of this nature both within and between receptor signal pathways that allows for fine regulation of cell activity, particularly that mediated through the control and modulation of Ca2+ concentrations.
MODELS FOR CROSS-TALK IN CELLULAR

SIGNAL TRANSDUCTION
At the level of second messenger, one can envisage that PKA-and PKC-dependent protein kinases could phosphorylate C-proteins and/or receptors that lead to activation of PLC and hence 1P3 generation, as well as intracellular receptors like that for 1P3, which is responsible for intracellular Ca2 mobilization.
The degree of phosphorylation could be sensitive to local concentrations of cyclic AMPand/or DAC.
CONCLUSIONS
A number of plasma membrane receptors in a range of cells and tissues are now known to generate more than one second messenger when activated by their physiological stimuli. Particularly prominent among these are signaling systems of the glucagon, calcitonin, and parathyroid hormone subclass that eventually generate cyclic AMP and/or 1P3, and ultimately mobilize intracellular and extracellular Ca2t
The evidence that certain cloned receptors, including the glucagon receptor, all induce Ca2+ mobilization and, where examined, generate inositol phosphates as well as cyclic AMP, provides an important avenue for issues concerning the ability of single receptors to couple to multiple signaling pathways to be resolved in molecular terms. The ability to modify key portions of the protein domains in the cloned PACAP receptor by mutagenesis and thereby alter its ability to regulate cyclic AMP or inositol phosphate levels differently (48) already provides (recent) evidence of such efforts. Added insights are being generated also by experiments like those of Kosugi and Mon (36), from which assignments for adenylyl cyclase Factors in the molecular machinery of these systems that appear important in providing the capability for coupling of receptors to multiple signaling pathways include the flexibility and versatility with which C-proteins interact with specific domains in the cytoplasmic loops of the receptors, on the one hand, and with enzymes like PLC and adenylate cyclase. on the other, that generate the second messengers.
An important feature of many of these receptors appears to be the dose-response relationship, which reveals that at relatively high concentrations of stimulus one of the second messengers is generated whereas the other second messenger is generated at relatively low concentrations.
Besides the abundance of evidence of fine regulation within a single signaling pathway, there is clear evidence also of possible regulatory interactions between different pathways.
Many of these appear to involve phosphorylation/dephosphorylation reactions. A further level of interaction occurs at intracellular sites away from the plasma membrane to where the second messengers have translocated from their site (or sites) of generation.
An example of this is the purported regulatory action of cyclic AMP-dependent protein kinase on the 1P3 receptor at the endoplasmic reticulum. Another second messenger generated by activation of a number of receptors, including glucagon, is diacylglycerol; its action, and that of Ca2, in stimulating protein kinase C is now well established and also appears to be involved in aspects of signaling cross-talk. 
